Abstract
Liver stiffness measurement (LSM) is frequently used as non-invasive alternative for liver fibrosis including cirrhosis, which can lead to portal hypertension. This study was conducted to evaluate the predictive value of LSM in cirrhosis-induced portal hypertension patients. Between July 2011 and December 2013, 153 participants were enrolled into a single-center, prospective, cross-sectional study. Each subject received both gastroscopy and LSM. Baseline biochemical, APRI, Fibroindex, and Fib-4 were also performed. LSM of cirrhosis patients with portal hypertension was significantly higher compared to those without portal hypertension (P < 0.05). A LSM ≥ 13.6 kPa had a sensitivity of 83.87 % and a specificity of 72.53 % with an accuracy of 77.1 for the prediction of portal hypertension, which are higher than those of APRI, Fib-4, and Fibroscan separately. A combination of Fibroscan combined with Fib-4 achieved a maximum AUC of 0.833 and accuracy of 77.8. Discriminant and internal validation analysis showed that Fibroscan plus APRI obtained a lower false negative rate compared to Fibroscan plus Fib-4 and Fibroscan plus Fibroindex (9.68, 17.74, and 11.29 %, respectively). A good relationship was found between LSM and NBI mean optical density both by linear and polynomial correlation analysis (r = 0.5533 and r = 0.7349, both P < 0.001). There was a trend toward a better performance of LSM for assessing portal hypertension compared with NBI gastroscopy mean optical density (P = 0.028 and P = 0.05, respectively). Better than APRI, Fibroindex, Fib-4, and NBI gastroscopy, LSM can predict portal hypertension in cirrhosis patients. A LSM of 13.6 kPa can be considered to be the predictive value for portal hypertension.
Similar content being viewed by others
References
Colecchia, A., Montrone, L., Scaioli, E., et al. (2012). Measurement of spleen stiffness to evaluate portal hypertension and the presence of esophageal varices in patients with HCV-related cirrhosis. Gastroenterology, 143(3), 646–654.
Hong, W. K., Kim, M. Y., Baik, S. K., et al. (2013). The usefulness of non-invasive liver stiffness measurements in predicting clinically significant portal hypertension in cirrhotic patients: Korean data. Clinical and Molecular Hepatology, 19(4), 370–375.
Suk, K. T., Baik, S. K., Yoon, J. H., et al. (2012). Revision and update on clinical practice guideline for liver cirrhosis. Korean Journal of Hepatology, 18(1), 1–21.
Zhao, C. Q., Zhou, Y., Ping, J., et al. (2014). Traditional Chinese medicine for treatment of liver diseases: progress, challenges and opportunities. Journal of Integrative Medicine, 12(5), 401–408.
de Franchis, R., & Baveno V Faculty. (2010). Revising consensus in portal hypertension: report of the Baveno V consensus workshop on methodology of diagnosis and therapy in portal hypertension. Journal of Hepatology, 53(4), 762–768.
Vizzutti, F., Arena, U., Romanelli, R. G., et al. (2007). Liver stiffness measurement predicts severe portal hypertension in patients with HCV-related cirrhosis. Hepatology, 45(5), 1290–1297.
Sandrin, L., Tanter, M., Gennisson, J. L., et al. (2002). Shear elasticity probe for soft tissues with 1-D transient elastography. IEEE Transactions on Ultrasonics, Ferroelectrics, and Frequency Control, 49(4), 436–446.
Bureau, C., Metivier, S., Peron, J. M., et al. (2008). Transient elastography accurately predicts presence of significant portal hypertension in patients with chronic liver disease. Alimentary Pharmacology & Therapeutics, 27(12), 1261–1268.
Lemoine, M., Katsahian, S., Ziol, M., et al. (2008). Liver stiffness measurement as a predictive tool of clinically significant portal hypertension in patients with compensated hepatitis C virus or alcohol-related cirrhosis. Alimentary Pharmacology & Therapeutics, 28(9), 1102–1110.
Foucher, J., Chanteloup, E., Vergniol, J., et al. (2006). Diagnosis of cirrhosis by transient elastography (FibroScan): A prospective study. Gut, 55(3), 403–408.
Kazemi, F., Kettaneh, A., N’kontchou, G., et al. (2006). Liver stiffness measurement selects patients with cirrhosis at risk of bearing large oesophageal varices. Journal of Hepatology, 45(2), 230–235.
Crisan, D., Radu, C., Lupsor, M., et al. (2012). Two or more synchronous combination of noninvasive tests to increase accuracy of liver fibrosis assessment in chronic hepatitis C; results from a cohort of 446 patients. Hepat Mon, 12(3), 177–184.
Wai, C. T., Greenson, J. K., Fontana, R. J., et al. (2003). A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology, 38(2), 518–526.
Koda, M., Matunaga, Y., Kawakami, M., et al. (2007). FibroIndex, a practical index for predicting significant fibrosis in patients with chronic hepatitis C. Hepatology, 45(2), 297–306.
Zhai, X. F., Chen, Z., Li, B., et al. (2013). Traditional herbal medicine in preventing recurrence after resection of small hepatocellular carcinoma: a multicenter randomized controlled trial. Journal of Integrative Medicine, 11(2), 90–100.
Ling, C. Q., Wang, L. N., Wang, Y., et al. (2014). The roles of traditional Chinese medicine in gene therapy. Journal of Integrative Medicine, 12(2), 67–75.
Bayraktar, Y., Balkanci, F., Uzunalimoglu, B., et al. (1996). Is portal hypertension due to liver cirrhosis a major factor in the development of portal hypertensive gastropathy? American Journal of Gastroenterology, 91(3), 554–558.
de Franchis, R. (2005). Evolving consensus in portal hypertension. Report of the Baveno IV consensus workshop on methodology of diagnosis and therapy in portal hypertension. Journal of Hepatology, 43(1), 167–176.
The French METAVIR Cooperative Study Group (1994). Intraobserver and interobserver variations in liver biopsy interpretation in patients with chronic hepatitis C. Hepatology, 20(1 Pt 1), 15–20.
Ziol, M., Handra-Luca, A., Kettaneh, A., et al. (2004). Non-invasive assessment of liver fibrosis by measurement of stiffness in patients with chronic hepatitis C. Hepatology, 41, 48–54.
Castera, L., Vergniol, J., Foucher, J., et al. (2005). Prospective comparison of transient elastography. Fibrotest, APRI and liver biopsy for the assessment of liver fibrosis in chronic hepatitis C. Gastroenterology, 128, 343–350.
Carrion, J. A., Navasa, M., Bosch, J., et al. (2006). Transient elastography for diagnosis of advanced fibrosis and portal hypertension in patients with hepatitis C recurrence after liver transplantation. Liver Transplantation, 12, 1791–1798.
Vallet-Pichard, A., Mallet, V., Nalpas, B., et al. (2007). Fib-4: an inexpensive and accurate marker of fibrosis in HCV infection. Comparison with liver biopsy and fibrotest. Hepatology, 46(1), 32–36.
Shi, K. Q., Fan, Y. C., Pan, Z. Z., et al. (2013). Transient elastography: A meta-analysis of diagnostic accuracy in evaluation of portal hypertension in chronic liver disease. Liver International, 33(1), 62–71.
Jung, H. S., Kim, Y. S., Kwon, O. S., et al. (2008). Usefulness of liver stiffness measurement for predicting the presence of esophageal varices in patients with liver cirrhosis. Korean Journal of Hepatology, 14(3), 342–350. (in Korean).
Song, H. Y., Zhang, L., Pan, J. L., et al. (2013). Bioactivity of five components of Chinese herbal formula Jiangzhi granules against hepatocellular steatosis. Journal of Integrative Medicine, 11(4), 262–268.
Hisabe, T., Yao, K., Beppu, T., et al. (2013). Validity of the usefulness of microvascular architecture and microsurface structure using magnifying endoscopy with narrow-band imaging in the colorectal neoplasm. Annals of Gastroenterology, 26(1), 45–51.
Song, J., Zhang, J., Wang, J., et al. (2014). Meta-analysis: Narrow band imaging for diagnosis of gastric intestinal metaplasia. PLoS ONE, 9(4), e94869.
Dong, S., & Su, S. B. (2014). Advances in mesenchymal stem cells combined with traditional Chinese medicine therapy for liver fibrosis. Journal of Integrative Medicine, 12(3), 147–155.
Huang, C. (2014). Natural modulators of liver X receptors. Journal of Integrative Medicine, 12(2), 76–85.
Acknowledgments
The authors thank Lüjin Li of Shanghai University of Traditional Chinese Medicine for his invaluable help with the statistical analysis.
Conflict of Interest
The authors declare that they have no competing interests.
Author information
Authors and Affiliations
Corresponding authors
Additional information
Wei Zhang and Liqiong Wang contributed equally to this work.
Rights and permissions
About this article
Cite this article
Zhang, W., Wang, L., Wang, L. et al. Liver Stiffness Measurement, Better than APRI, Fibroindex, Fib-4, and NBI Gastroscopy, Predicts Portal Hypertension in Patients with Cirrhosis. Cell Biochem Biophys 71, 865–873 (2015). https://doi.org/10.1007/s12013-014-0275-z
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12013-014-0275-z